{"nct_id":"NCT03916627","title":"Neoadjuvant Cemiplimab for the Treatment of Resectable NSCLC, HCC, and HNSCC in Adult Patients","status":"ACTIVE_NOT_RECRUITING","status_verified_date":"2025-04","start_date":"2019-07-23","start_date_type":"ACTUAL","primary_completion_date":"2025-03-31","primary_completion_date_type":"ACTUAL","completion_date":"2030-05-14","completion_date_type":"ESTIMATED","phases":["PHASE2"],"tickers":["REGN"]}